Author: Sepúlveda-Beltran, D.; Mondragón-Cardona, A.; Conde-Martin, C. E.; Lopez-Guevara, O. A.; Hernandez-Rojas, N. R.; Caviedes-Cleves, M. A.; Gutierrez-Ortega, D. E.; Rangel-Meza, C. R.; Conde-Tavera, F. K.; Rodriguez-Morales, A. J.; Dhama, K.
Title: Generalized urticaria as a vasculitic manifestation in a patient with SARS-CoV-2 infection: A case report in Colombia Cord-id: to967gbg Document date: 2021_1_1
ID: to967gbg
Snippet: Skin manifestations have been reported in up to 20% of cases of SARS-CoV-2 infection, including morbilliform rash (22%), pernio-like acral lesions (18%), urticaria (16%), and macular erythema (13%). It is believed that in the case of SARS-CoV-2 infection, the mechanism involved is an inflammatory response that generates immune dysregulation, vascular congestion, vasculitis, vascular thrombosis, or neoangiogenesis. This case study, present the case of a patient with no previous history of urticar
Document: Skin manifestations have been reported in up to 20% of cases of SARS-CoV-2 infection, including morbilliform rash (22%), pernio-like acral lesions (18%), urticaria (16%), and macular erythema (13%). It is believed that in the case of SARS-CoV-2 infection, the mechanism involved is an inflammatory response that generates immune dysregulation, vascular congestion, vasculitis, vascular thrombosis, or neoangiogenesis. This case study, present the case of a patient with no previous history of urticarial reactions, autoimmune diseases, or exposure to medications who develops generalized urticaria lasting more than 24 hours and who was diagnosed with SARS-CoV-2 infection by RT-PCR with a nasopharyngeal swab. We suggest in this patient vasculitic urticaria as a manifestation of SARS-CoV-2 infection. © 2021, Editorial board of Journal of Experimental Biology and Agricultural Sciences. All rights reserved.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date